182 related articles for article (PubMed ID: 32720336)
21. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines?
Gumaste PV; Fleming NH; Silva I; Shapiro RL; Berman RS; Zhong J; Osman I; Stein JA
J Natl Compr Canc Netw; 2014 Dec; 12(12):1706-12. PubMed ID: 25505211
[TBL] [Abstract][Full Text] [Related]
22. Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma.
Kurtansky NR; Manci RN; Bello DM; Adamson AS; Shoushtari AN; Wehner MR; Ariyan CE; Marghoob AA; Marchetti MA; Rotemberg V
Br J Dermatol; 2022 Sep; 187(3):430-432. PubMed ID: 35318644
[No Abstract] [Full Text] [Related]
23. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.
Rokuhara S; Saida T; Oguchi M; Matsumoto K; Murase S; Oguchi S
J Am Acad Dermatol; 2004 May; 50(5):695-700. PubMed ID: 15097952
[TBL] [Abstract][Full Text] [Related]
24. Acral cutaneous melanoma in caucasians: clinical features, histopathology and prognosis in 112 patients.
Kuchelmeister C; Schaumburg-Lever G; Garbe C
Br J Dermatol; 2000 Aug; 143(2):275-80. PubMed ID: 10951133
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
[TBL] [Abstract][Full Text] [Related]
26. "Gloves-and-socks" melanoma: does histology make a difference?
Soudry E; Gutman H; Feinmesser M; Gutman R; Schachter J
Dermatol Surg; 2008 Oct; 34(10):1372-8. PubMed ID: 18616532
[TBL] [Abstract][Full Text] [Related]
27. Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Tyrrell JS; Morton C; Campbell SM; Curnow A
Br J Dermatol; 2011 Jun; 164(6):1362-8. PubMed ID: 21564050
[TBL] [Abstract][Full Text] [Related]
28. Time-varying pattern of recurrence risk for localized melanoma in China.
Wen X; Li D; Zhao J; Li J; Yang T; Ding Y; Peng R; Zhu B; Huang F; Zhang X
World J Surg Oncol; 2020 Jan; 18(1):6. PubMed ID: 31901239
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China.
Hao M; Zhao G; Du X; Yang Y; Yang J
Tumour Biol; 2016 Aug; 37(8):10339-48. PubMed ID: 26846098
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic Characteristics of Trauma-Related Nail Apparatus Melanoma: A Comparative Study according to the Presence of Trauma prior to Melanoma Development.
Choi ME; Cho H; Won CH; Chang SE; Lee MW; Lee WJ
Dermatology; 2023; 239(1):165-173. PubMed ID: 35878586
[TBL] [Abstract][Full Text] [Related]
31. Genetic alterations in primary melanoma in Taiwan.
Sheen YS; Tan KT; Tse KP; Liao YH; Lin MH; Chen JS; Liau JY; Tseng YJ; Lee CH; Hong CH; Liao JB; Chang HT; Chu CY
Br J Dermatol; 2020 May; 182(5):1205-1213. PubMed ID: 31408190
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and prognostic characteristics of acral metastases in patients with malignant disease: A retrospective study.
Çiftdemir M; Ustabaşıoğlu FE; Çölbe SA; Üstün F; Usta U; Çiçin İ
Acta Orthop Traumatol Turc; 2021 Jan; 55(1):67-72. PubMed ID: 33650515
[TBL] [Abstract][Full Text] [Related]
33. Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry.
Cho J; Ahn S; Yoo KH; Kim JH; Choi SH; Jang KT; Lee J
Invest New Drugs; 2016 Dec; 34(6):677-684. PubMed ID: 27491654
[TBL] [Abstract][Full Text] [Related]
34. Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.
Gui J; Guo Z; Wu D
J Transl Med; 2022 Aug; 20(1):367. PubMed ID: 35974375
[TBL] [Abstract][Full Text] [Related]
35. Fine Needle Aspiration Cytology (FNAC) for Chinese Patients With Acral and Cutaneous Melanoma: Accuracy and Safety Analysis From a Single Institution.
Yang L; Sun W; Xu Y; Zhang X; Wang S; Wang C; Chen Y
Front Oncol; 2020; 10():1724. PubMed ID: 33194572
[TBL] [Abstract][Full Text] [Related]
36. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
[TBL] [Abstract][Full Text] [Related]
37. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneous spectrum of acral melanoma: A clinicoprognostic study of 213 acral melanomas according to tumor site.
Moon HR; Kang HJ; Won CH; Chang SE; Lee MW; Choi JH; Lee WJ
J Am Acad Dermatol; 2018 Jan; 78(1):179-182.e3. PubMed ID: 29241776
[No Abstract] [Full Text] [Related]
39. [Predictive value of sentinel lymph node biopsy in prognosis of acral melanoma].
Liu WF; Yang FJ; Niu XH; Sun Y; Huang Z; Jin T; Li Y; Ding Y; Yang F; Chen T
Zhonghua Zhong Liu Za Zhi; 2021 Jan; 43(1):147-154. PubMed ID: 33472329
[No Abstract] [Full Text] [Related]
40. Differences between acral and nonacral melanoma genomes.
Johansson P
Br J Dermatol; 2020 May; 182(5):1085. PubMed ID: 31742660
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
